FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

7591811000001103: Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22989501000001113 Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
42366501000001111 Cytarabine (liposomal) 50mg/5ml suspension for injection vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial Is pack of Cytarabine 50mg/5ml intrathecal suspension for injection vials false Inferred relationship Existential restriction modifier
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial Has active ingredient Cytarabine false Inferred relationship Existential restriction modifier
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial Has manufactured dose form Conventional release suspension for injection false Inferred relationship Existential restriction modifier
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial Has VMP Cytarabine 50mg/5ml intrathecal suspension for injection vials true Inferred relationship Existential restriction modifier
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial Has specific active ingredient Cytarabine false Inferred relationship Existential restriction modifier
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial Has dispensed dose form Conventional release suspension for injection true Inferred relationship Existential restriction modifier
Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial Has specific active ingredient Cytarabine liposomal pegylated true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
DepoCyte 50mg/5ml intrathecal suspension for injection vials (Napp Pharmaceuticals Ltd) 1 vial Is a True Cytarabine 50mg/5ml intrathecal suspension for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start